HNGE insider Form 4 shows director selling Class A stock

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) reported that one of its directors sold Class A common stock in two transactions. On 11/18/2025, the director sold 2,187 shares at an average price of $40.4556, leaving 32,813 shares beneficially owned. On 11/19/2025, the director sold an additional 3,813 shares at a weighted average price of $43.603, with a remaining holding of 29,000 shares, all held directly.

The company notes that the weighted average price on 11/19/2025 reflects individual sale prices between $43.51 and $43.73, and undertakes to provide detailed breakdowns of the shares sold at each price upon request.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Leslie Kristina M

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	11/18/2025		S		2,187	D	$40.4556	32,813	D
Class A Common Stock	11/19/2025		S		3,813	D	$43.603(1)	29,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the weighted average sale price. The lowest price at which shares were sold was $43.51 and the highest price at which shares were sold was $43.73. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

	/s/ David Wood, Attorney-in-Fact	11/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Hinge Health, Inc. (HNGE) disclose?

Hinge Health, Inc. disclosed that a director sold shares of the company’s Class A common stock in two separate transactions on 11/18/2025 and 11/19/2025.

How many HNGE shares were sold in the reported transactions?

The director sold 2,187 shares of Class A common stock on 11/18/2025 and 3,813 shares on 11/19/2025.

At what prices were HNGE shares sold in the Form 4 filing?

On 11/18/2025, shares were sold at an average price of $40.4556. On 11/19/2025, shares were sold at a weighted average price of $43.603, with individual prices ranging from $43.51 to $43.73.

How many HNGE shares does the reporting person own after these sales?

After the sales, the director beneficially owns 29,000 shares of Hinge Health, Inc. Class A common stock, held directly.

What does the weighted average sale price mean in the HNGE Form 4?

The weighted average sale price of $43.603 on 11/19/2025 reflects multiple trades within a range of $43.51 to $43.73. The filer states they will provide the exact number of shares sold at each price within this range upon request.

What is the relationship of the reporting person to Hinge Health, Inc. (HNGE)?

The reporting person identified in the Form 4 is a director of Hinge Health, Inc.